Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07455084) titled 'A Study to Detect the Radioactivity of 14C-SEP-380135 in Urine and Feces in Healthy Male Adults' on March 3.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition:
Schizophrenia
Intervention:
Drug: 14C-SEP-380135
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: March 20, 2026
Target Sample Size: 8
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/st...